TRAVERE THERAPEUTICS, INC.: revenue
| Value | {"amount": 154937000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-12-31 |
| Status | current |
| Entity | TRAVERE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:10:36.228718+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c4cce77e-ff82-4c9b-9f5e-97faa809a08f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001438533-19-000003Retrieved: 2026-08-19T14:10:36.228718+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001438533/revenue/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c4cce77e-ff82-4c9b-9f5e-97faa809a08f
History
- supersedes {"amount": 154937000, "concept": "us-gaap:SalesRevenueGoodsNet", "currency": "USD"} (evidence 0001438533-18-000006)